Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,107,986

« Back to Dashboard
Patent 7,107,986 protects FLOVENT HFA, ADVAIR HFA, and VENTOLIN HFA, and is included in three NDAs.

Protection for FLOVENT HFA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 7,107,986

Title:Dispenser with doses' counter
Abstract:There is provided a dispenser suitable for dispensing medicament, particularly medicament for use in the treatment of respiratory disorders. The dispenser comprises a housing having a support; a container, locatable within said housing, having an outlet, wherein said container dispenses through said outlet in response to movement of the container relative to the housing; and an actuation indicator having an indexing mechanism actuatable by movement of the container relative to the housing. A couple mechanism is provided which couples the indexing mechanism to the container to compensate for any variation in pre-actuation positionings of the indexing mechanism and container.
Inventor(s): Rand; Paul Kenneth (Redhill, GB), Brand; Peter John (Royston, GB), Godfrey; James William (Hertfordshire, GB)
Assignee: Glaxo Group Limited (Greenford, GB)
Application Number:10/465,109
Patent Claim Types:
see list of patent claims
Patent Metrics:
Source: PatentQuant.com
Field: Medical technology
Back Citations: 178th percentile
Forward Citations: 10th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-003May 14, 2004RXYes7,107,986*PEDDec 8, 2018Y
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-002May 14, 2004RXYes7,107,986*PEDDec 8, 2018Y
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-001May 14, 2004RXYes7,107,986*PEDDec 8, 2018Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,107,986

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9711889Jun 10, 1997
United Kingdom9721875Oct 16, 1997

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.